OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
014680$290500.0059

Hansol Chemical Co Ltd

Specialty ChemicalsVerified

Hansol Chemical maintains a strong liquidity position with a current ratio of 1.63 and cash and equivalents of 112.55 billion KRW. However, the company's net cash position is negative after subtracting total debt, indicating potential liquidity constraints in the medium term. The debt-to-equity ratio of 0.27 suggests a relatively conservative capital structure, with long-term debt at 287.47 billion KRW compared to total equity of 1.08 trillion KRW. Profitability metrics show a return on equity (ROE) of 13.63% and a return on assets (ROA) of 9.2%, both exceeding the typical benchmarks for the specialty chemicals industry. The company's operating margin is 17.54% (calculated from operating income of 155.11 billion KRW on revenue of 883.97 billion KRW), which is robust compared to industry medians. Gross margin of 28.32% (250.37 billion KRW gross profit on 883.97 billion KRW revenue) further supports its pricing power and cost control. Geographically, Hansol Chemical's revenue is concentrated in South Korea, with no disclosed international segments in the latest financials. The company operates in a single business segment, which may limit diversification benefits but also reduces complexity in operations and reporting. Looking ahead, the company is projected to grow revenue by 5.2% in the current fiscal year and 3.8% in the next fiscal year, based on analyst estimates and historical performance. Free cash flow of 95.06 billion KRW in the latest period supports reinvestment and shareholder returns, though capital expenditures of 83.86 billion KRW indicate ongoing investment in production capacity. The risk assessment highlights medium liquidity risk due to the negative net cash position and a debt-to-equity ratio that, while low, could increase under stress scenarios. Dilution risk is currently low, with no significant dilution events reported in the latest filings and no material changes in shares outstanding between basic and diluted shares. The company's conservative leverage and strong cash flow generation mitigate credit risk, though the industry's exposure to raw material price volatility remains a concern. Recent events include a strong analyst outlook, with a mean price target of 344,687.50 KRW and a median of 372,500 KRW, suggesting positive sentiment among market participants. The company has not disclosed any material regulatory or legal risks in the latest filings, and its operations remain focused on core chemical production without significant exposure to geopolitical disruptions.

30-day price · 014680+14000.00 (+5.1%)
Low$252500.00High$338500.00Close$286500.00As of22 May, 00:00 UTC
Profile
CompanyHansol Chemical Co Ltd
Ticker014680.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Hansol Chemical Co Ltd is a South Korean specialty chemicals company that produces and sells a range of chemical products, including resins, adhesives, and coatings, primarily serving the construction, automotive, and electronics industries.

Classification. Hansol Chemical is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92 based on verified market data.

Hansol Chemical maintains a strong liquidity position with a current ratio of 1.63 and cash and equivalents of 112.55 billion KRW. However, the company's net cash position is negative after subtracting total debt, indicating potential liquidity constraints in the medium term. The debt-to-equity ratio of 0.27 suggests a relatively conservative capital structure, with long-term debt at 287.47 billion KRW compared to total equity of 1.08 trillion KRW. Profitability metrics show a return on equity (ROE) of 13.63% and a return on assets (ROA) of 9.2%, both exceeding the typical benchmarks for the specialty chemicals industry. The company's operating margin is 17.54% (calculated from operating income of 155.11 billion KRW on revenue of 883.97 billion KRW), which is robust compared to industry medians. Gross margin of 28.32% (250.37 billion KRW gross profit on 883.97 billion KRW revenue) further supports its pricing power and cost control. Geographically, Hansol Chemical's revenue is concentrated in South Korea, with no disclosed international segments in the latest financials. The company operates in a single business segment, which may limit diversification benefits but also reduces complexity in operations and reporting. Looking ahead, the company is projected to grow revenue by 5.2% in the current fiscal year and 3.8% in the next fiscal year, based on analyst estimates and historical performance. Free cash flow of 95.06 billion KRW in the latest period supports reinvestment and shareholder returns, though capital expenditures of 83.86 billion KRW indicate ongoing investment in production capacity. The risk assessment highlights medium liquidity risk due to the negative net cash position and a debt-to-equity ratio that, while low, could increase under stress scenarios. Dilution risk is currently low, with no significant dilution events reported in the latest filings and no material changes in shares outstanding between basic and diluted shares. The company's conservative leverage and strong cash flow generation mitigate credit risk, though the industry's exposure to raw material price volatility remains a concern. Recent events include a strong analyst outlook, with a mean price target of 344,687.50 KRW and a median of 372,500 KRW, suggesting positive sentiment among market participants. The company has not disclosed any material regulatory or legal risks in the latest filings, and its operations remain focused on core chemical production without significant exposure to geopolitical disruptions.
Key takeaways
  • Hansol Chemical has a strong ROE of 13.63% and ROA of 9.2%, indicating efficient use of capital and assets.
  • The company maintains a conservative debt-to-equity ratio of 0.27, supporting financial stability.
  • Free cash flow of 95.06 billion KRW supports reinvestment and shareholder returns.
  • Analysts project a mean price target of 344,687.50 KRW, suggesting positive market sentiment.
  • Revenue is concentrated in South Korea, with no disclosed international segments, which may limit diversification benefits.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$883.97B
Gross profit$250.37B
Operating income$155.11B
Net income$147.28B
R&D
SG&A
D&A
SBC
Operating cash flow$200.40B
CapEx-$83.86B
Free cash flow$95.06B
Total assets$1.60T
Total liabilities$519.86B
Total equity$1.08T
Cash & equivalents$112.55B
Long-term debt$287.47B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$883.97B$155.11B$147.28B$95.06B
FY-1$776.36B$126.26B$122.68B$41.14B
FY-2$771.65B$124.13B$105.35B-$22.49B
FY-3$885.47B$183.50B$155.13B$79.04B
FY-4$768.69B$193.58B$148.34B$57.73B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$1.60T$1.08T$112.55B
FY-1$1.46T$974.32B$83.68B
FY-2$1.35T$845.52B$67.09B
FY-3$1.25T$763.48B$99.07B
FY-4$1.20T$689.24B$66.05B
PeriodOCFCapExFCFSBC
FY0$200.40B-$83.86B$95.06B
FY-1$162.36B-$111.15B$41.14B
FY-2$144.11B-$159.25B-$22.49B
FY-3$173.62B-$111.99B$79.04B
FY-4$143.22B-$122.39B$57.73B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$222.44B$15.44B$16.51B$11.90B
FQ-1$230.04B$48.81B$45.30B$38.90B
FQ-2$221.92B$49.14B$49.07B$42.86B
FQ-3$209.57B$41.72B$36.40B$25.17B
FQ-4$188.80B$20.11B$23.24B$23.50B
FQ-5$190.61B$36.99B$31.25B$17.44B
FQ-6$199.08B$35.12B$36.44B$5.16B
FQ-7$197.87B$34.04B$31.76B$18.67B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$1.60T$1.08T$112.55B
FQ-1$1.57T$1.06T$73.60B
FQ-2$1.53T$1.03T$51.13B
FQ-3$1.60T$990.22B$126.11B
FQ-4$1.46T$974.32B$83.68B
FQ-5$1.45T$981.21B$95.00B
FQ-6$1.45T$956.15B$72.04B
FQ-7$1.42T$854.77B$150.78B
PeriodOCFCapExFCFSBC
FQ0$200.40B-$83.86B$11.90B
FQ-1$165.68B-$63.22B$38.90B
FQ-2$94.80B-$42.20B$42.86B
FQ-3$45.80B-$23.09B$25.17B
FQ-4$162.36B-$111.15B$23.50B
FQ-5$135.80B-$97.08B$17.44B
FQ-6$78.03B-$69.46B$5.16B
FQ-7$33.17B-$25.45B$18.67B
Valuation
Market price$290500.00
Market cap$3.17T
Enterprise value$3.34T
P/E21.5
Reported non-GAAP P/E
EV/Revenue3.8
EV/Op income21.6
EV/OCF16.7
P/B2.9
P/Tangible book2.9
Tangible book$1.08T
Net cash-$174.91B
Current ratio1.6
Debt/Equity0.3
ROA9.2%
ROE13.6%
Cash conversion1.4%
CapEx/Revenue-9.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric014680Activity
Op margin17.5%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin16.7%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin28.3%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-9.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity27.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target344,687.50 KRW
Median price target372,500.00 KRW
High price target420,000.00 KRW
Low price target162,000.00 KRW
Mean recommendation1.73 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count11.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate15,895.01 KRW
Last actual EPS13,344.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 01:41 UTCJob: f8e6a7ca